北京时间5月15日收盘,ORIC市盈率为-34.97,ORIC市值为9亿美元

ORIC简介

OricPharmaceuticals,Inc.isaclinical-stagebiopharmaceuticalcompanydedicatedtoimprovingpatients’livesbyOvercomingResistanceInCancer.Profoundadvancementsinoncologydrugdevelopmenthaveexpandedthetreatmentoptionsavailabletopatients,yettherapeuticresistanceandrelapsecontinuetolimittheefficacyanddurationofclinicalbenefitofsuchtreatments.Collectively,itsfoundersandmanagementteamhaveadecades-longheritageofidentifyingandcharacterizingresistancemechanismsinoncology,havingdiscoveredanddevelopedgroundbreakingmedicinesatcompaniessuchasIgnyta,Medivation,AragonandGenentech.